Molecular Characterization of Cefoxitin-Resistant Escherichia coli from Canadian Hospitals

Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Antimicrobial Agents and Chemotherapy 2005-01, Vol.49 (1), p.358-365
Hauptverfasser: Michael R. Mulvey, Elizabeth Bryce, David A. Boyd, Marianna Ofner-Agostini, Allison M. Land, Andrew E. Simor, Shirley Paton, the Canadian Hospital Epidemiology Committee, the Canadian Nosocomial Infection Surveillance Program, Health Canada
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 365
container_issue 1
container_start_page 358
container_title Antimicrobial Agents and Chemotherapy
container_volume 49
creator Michael R. Mulvey
Elizabeth Bryce
David A. Boyd
Marianna Ofner-Agostini
Allison M. Land
Andrew E. Simor
Shirley Paton
the Canadian Hospital Epidemiology Committee
the Canadian Nosocomial Infection Surveillance Program, Health Canada
description Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC       
doi_str_mv 10.1128/AAC.49.1.358-365.2005
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_67336237</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67336237</sourcerecordid><originalsourceid>FETCH-LOGICAL-a537t-94b4aad0798c1dd4173d23be70c220818d916930136f04bdb4e431d49696ab813</originalsourceid><addsrcrecordid>eNqFkU1v1DAQhi0EokvhJ4BygVuCv2MfOKyiliIVISG4cLEmjtO4ytqLnRTor8fVrlo49TSy_LyeGT8IvSa4IYSq99tt13DdkIYJVTMpGoqxeII2BGtVS6HlU7TBWMqaK8xP0Iucr3E5C42foxMiJJGMyA368TnOzq4zpKqbIIFdXPK3sPgYqjhWnRvjb7_4UH912ecFwlKdZTsVyE4eKhtnX40p7qoOAgweQnUR894vMOeX6NlYint1rKfo-_nZt-6ivvzy8VO3vaxBsHapNe85wIBbrSwZBk5aNlDWuxZbSrEiatBEaoYJkyPm_dBzxxkZuJZaQq8IO0UfDu_u137nBuvCkmA2--R3kP6YCN78fxP8ZK7ijRFMKYlL_t0xn-LP1eXF7Hy2bp4huLhmI1vGJGXtoyBpW8mYYAUUB9CmmHNy4_0wBJs7e6bYM1wbYoo9U-yZO3slRw85yDtqruOaQvm4R0Nv_l3_odXRcQHeHgHIFuYxQbA-P3BSSEqZKlx14CZ_Nf3yyZkyhgGw903ZX8L7vcY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17763353</pqid></control><display><type>article</type><title>Molecular Characterization of Cefoxitin-Resistant Escherichia coli from Canadian Hospitals</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Michael R. Mulvey ; Elizabeth Bryce ; David A. Boyd ; Marianna Ofner-Agostini ; Allison M. Land ; Andrew E. Simor ; Shirley Paton ; the Canadian Hospital Epidemiology Committee ; the Canadian Nosocomial Infection Surveillance Program, Health Canada</creator><creatorcontrib>Michael R. Mulvey ; Elizabeth Bryce ; David A. Boyd ; Marianna Ofner-Agostini ; Allison M. Land ; Andrew E. Simor ; Shirley Paton ; the Canadian Hospital Epidemiology Committee ; the Canadian Nosocomial Infection Surveillance Program, Health Canada ; Members of the Canadian Hospital Epidemiology Committee are listed in Acknowledgments ; Members of the Canadian Nosocomial Infection Surveillance Program are listed in Acknowledgments</creatorcontrib><description>Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions &amp; Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC       </description><identifier>ISSN: 0066-4804</identifier><identifier>EISSN: 1098-6596</identifier><identifier>DOI: 10.1128/AAC.49.1.358-365.2005</identifier><identifier>PMID: 15616316</identifier><identifier>CODEN: AACHAX</identifier><language>eng</language><publisher>Washington, DC: American Society for Microbiology</publisher><subject>Anti-Bacterial Agents ; Anti-Bacterial Agents - pharmacology ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Bacterial Proteins - chemistry ; Bacterial Proteins - genetics ; Base Sequence ; beta-Lactamases - chemistry ; beta-Lactamases - genetics ; Biological and medical sciences ; Canada - epidemiology ; Cefoxitin ; Cefoxitin - pharmacology ; Cephalosporin Resistance ; Electrophoresis, Gel, Pulsed-Field ; Escherichia coli ; Escherichia coli - drug effects ; Escherichia coli Infections ; Escherichia coli Infections - epidemiology ; Escherichia coli Infections - microbiology ; Hospitals ; Humans ; Mechanisms of Resistance ; Medical sciences ; Microbial Sensitivity Tests ; Molecular Sequence Data ; Mutation ; Pharmacology. Drug treatments ; Population Surveillance ; Promoter Regions, Genetic ; Prospective Studies ; Sequence Analysis, DNA</subject><ispartof>Antimicrobial Agents and Chemotherapy, 2005-01, Vol.49 (1), p.358-365</ispartof><rights>2005 INIST-CNRS</rights><rights>Copyright © 2005 American Society for Microbiology</rights><rights>Copyright © 2005, American Society for Microbiology 2005</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a537t-94b4aad0798c1dd4173d23be70c220818d916930136f04bdb4e431d49696ab813</citedby><cites>FETCH-LOGICAL-a537t-94b4aad0798c1dd4173d23be70c220818d916930136f04bdb4e431d49696ab813</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC538860/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC538860/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,4024,27923,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16562238$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15616316$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Michael R. Mulvey</creatorcontrib><creatorcontrib>Elizabeth Bryce</creatorcontrib><creatorcontrib>David A. Boyd</creatorcontrib><creatorcontrib>Marianna Ofner-Agostini</creatorcontrib><creatorcontrib>Allison M. Land</creatorcontrib><creatorcontrib>Andrew E. Simor</creatorcontrib><creatorcontrib>Shirley Paton</creatorcontrib><creatorcontrib>the Canadian Hospital Epidemiology Committee</creatorcontrib><creatorcontrib>the Canadian Nosocomial Infection Surveillance Program, Health Canada</creatorcontrib><creatorcontrib>Members of the Canadian Hospital Epidemiology Committee are listed in Acknowledgments</creatorcontrib><creatorcontrib>Members of the Canadian Nosocomial Infection Surveillance Program are listed in Acknowledgments</creatorcontrib><title>Molecular Characterization of Cefoxitin-Resistant Escherichia coli from Canadian Hospitals</title><title>Antimicrobial Agents and Chemotherapy</title><addtitle>AAC</addtitle><addtitle>Antimicrob Agents Chemother</addtitle><description>Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions &amp; Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC       </description><subject>Anti-Bacterial Agents</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Bacterial Proteins - chemistry</subject><subject>Bacterial Proteins - genetics</subject><subject>Base Sequence</subject><subject>beta-Lactamases - chemistry</subject><subject>beta-Lactamases - genetics</subject><subject>Biological and medical sciences</subject><subject>Canada - epidemiology</subject><subject>Cefoxitin</subject><subject>Cefoxitin - pharmacology</subject><subject>Cephalosporin Resistance</subject><subject>Electrophoresis, Gel, Pulsed-Field</subject><subject>Escherichia coli</subject><subject>Escherichia coli - drug effects</subject><subject>Escherichia coli Infections</subject><subject>Escherichia coli Infections - epidemiology</subject><subject>Escherichia coli Infections - microbiology</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Mechanisms of Resistance</subject><subject>Medical sciences</subject><subject>Microbial Sensitivity Tests</subject><subject>Molecular Sequence Data</subject><subject>Mutation</subject><subject>Pharmacology. Drug treatments</subject><subject>Population Surveillance</subject><subject>Promoter Regions, Genetic</subject><subject>Prospective Studies</subject><subject>Sequence Analysis, DNA</subject><issn>0066-4804</issn><issn>1098-6596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1v1DAQhi0EokvhJ4BygVuCv2MfOKyiliIVISG4cLEmjtO4ytqLnRTor8fVrlo49TSy_LyeGT8IvSa4IYSq99tt13DdkIYJVTMpGoqxeII2BGtVS6HlU7TBWMqaK8xP0Iucr3E5C42foxMiJJGMyA368TnOzq4zpKqbIIFdXPK3sPgYqjhWnRvjb7_4UH912ecFwlKdZTsVyE4eKhtnX40p7qoOAgweQnUR894vMOeX6NlYint1rKfo-_nZt-6ivvzy8VO3vaxBsHapNe85wIBbrSwZBk5aNlDWuxZbSrEiatBEaoYJkyPm_dBzxxkZuJZaQq8IO0UfDu_u137nBuvCkmA2--R3kP6YCN78fxP8ZK7ijRFMKYlL_t0xn-LP1eXF7Hy2bp4huLhmI1vGJGXtoyBpW8mYYAUUB9CmmHNy4_0wBJs7e6bYM1wbYoo9U-yZO3slRw85yDtqruOaQvm4R0Nv_l3_odXRcQHeHgHIFuYxQbA-P3BSSEqZKlx14CZ_Nf3yyZkyhgGw903ZX8L7vcY</recordid><startdate>20050101</startdate><enddate>20050101</enddate><creator>Michael R. Mulvey</creator><creator>Elizabeth Bryce</creator><creator>David A. Boyd</creator><creator>Marianna Ofner-Agostini</creator><creator>Allison M. Land</creator><creator>Andrew E. Simor</creator><creator>Shirley Paton</creator><creator>the Canadian Hospital Epidemiology Committee</creator><creator>the Canadian Nosocomial Infection Surveillance Program, Health Canada</creator><general>American Society for Microbiology</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>C1K</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20050101</creationdate><title>Molecular Characterization of Cefoxitin-Resistant Escherichia coli from Canadian Hospitals</title><author>Michael R. Mulvey ; Elizabeth Bryce ; David A. Boyd ; Marianna Ofner-Agostini ; Allison M. Land ; Andrew E. Simor ; Shirley Paton ; the Canadian Hospital Epidemiology Committee ; the Canadian Nosocomial Infection Surveillance Program, Health Canada</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a537t-94b4aad0798c1dd4173d23be70c220818d916930136f04bdb4e431d49696ab813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Anti-Bacterial Agents</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Bacterial Proteins - chemistry</topic><topic>Bacterial Proteins - genetics</topic><topic>Base Sequence</topic><topic>beta-Lactamases - chemistry</topic><topic>beta-Lactamases - genetics</topic><topic>Biological and medical sciences</topic><topic>Canada - epidemiology</topic><topic>Cefoxitin</topic><topic>Cefoxitin - pharmacology</topic><topic>Cephalosporin Resistance</topic><topic>Electrophoresis, Gel, Pulsed-Field</topic><topic>Escherichia coli</topic><topic>Escherichia coli - drug effects</topic><topic>Escherichia coli Infections</topic><topic>Escherichia coli Infections - epidemiology</topic><topic>Escherichia coli Infections - microbiology</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Mechanisms of Resistance</topic><topic>Medical sciences</topic><topic>Microbial Sensitivity Tests</topic><topic>Molecular Sequence Data</topic><topic>Mutation</topic><topic>Pharmacology. Drug treatments</topic><topic>Population Surveillance</topic><topic>Promoter Regions, Genetic</topic><topic>Prospective Studies</topic><topic>Sequence Analysis, DNA</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Michael R. Mulvey</creatorcontrib><creatorcontrib>Elizabeth Bryce</creatorcontrib><creatorcontrib>David A. Boyd</creatorcontrib><creatorcontrib>Marianna Ofner-Agostini</creatorcontrib><creatorcontrib>Allison M. Land</creatorcontrib><creatorcontrib>Andrew E. Simor</creatorcontrib><creatorcontrib>Shirley Paton</creatorcontrib><creatorcontrib>the Canadian Hospital Epidemiology Committee</creatorcontrib><creatorcontrib>the Canadian Nosocomial Infection Surveillance Program, Health Canada</creatorcontrib><creatorcontrib>Members of the Canadian Hospital Epidemiology Committee are listed in Acknowledgments</creatorcontrib><creatorcontrib>Members of the Canadian Nosocomial Infection Surveillance Program are listed in Acknowledgments</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Antimicrobial Agents and Chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Michael R. Mulvey</au><au>Elizabeth Bryce</au><au>David A. Boyd</au><au>Marianna Ofner-Agostini</au><au>Allison M. Land</au><au>Andrew E. Simor</au><au>Shirley Paton</au><au>the Canadian Hospital Epidemiology Committee</au><au>the Canadian Nosocomial Infection Surveillance Program, Health Canada</au><aucorp>Members of the Canadian Hospital Epidemiology Committee are listed in Acknowledgments</aucorp><aucorp>Members of the Canadian Nosocomial Infection Surveillance Program are listed in Acknowledgments</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Molecular Characterization of Cefoxitin-Resistant Escherichia coli from Canadian Hospitals</atitle><jtitle>Antimicrobial Agents and Chemotherapy</jtitle><stitle>AAC</stitle><addtitle>Antimicrob Agents Chemother</addtitle><date>2005-01-01</date><risdate>2005</risdate><volume>49</volume><issue>1</issue><spage>358</spage><epage>365</epage><pages>358-365</pages><issn>0066-4804</issn><eissn>1098-6596</eissn><coden>AACHAX</coden><abstract>Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions &amp; Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC       </abstract><cop>Washington, DC</cop><pub>American Society for Microbiology</pub><pmid>15616316</pmid><doi>10.1128/AAC.49.1.358-365.2005</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0066-4804
ispartof Antimicrobial Agents and Chemotherapy, 2005-01, Vol.49 (1), p.358-365
issn 0066-4804
1098-6596
language eng
recordid cdi_proquest_miscellaneous_67336237
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Anti-Bacterial Agents
Anti-Bacterial Agents - pharmacology
Antibiotics. Antiinfectious agents. Antiparasitic agents
Bacterial Proteins - chemistry
Bacterial Proteins - genetics
Base Sequence
beta-Lactamases - chemistry
beta-Lactamases - genetics
Biological and medical sciences
Canada - epidemiology
Cefoxitin
Cefoxitin - pharmacology
Cephalosporin Resistance
Electrophoresis, Gel, Pulsed-Field
Escherichia coli
Escherichia coli - drug effects
Escherichia coli Infections
Escherichia coli Infections - epidemiology
Escherichia coli Infections - microbiology
Hospitals
Humans
Mechanisms of Resistance
Medical sciences
Microbial Sensitivity Tests
Molecular Sequence Data
Mutation
Pharmacology. Drug treatments
Population Surveillance
Promoter Regions, Genetic
Prospective Studies
Sequence Analysis, DNA
title Molecular Characterization of Cefoxitin-Resistant Escherichia coli from Canadian Hospitals
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T17%3A13%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Molecular%20Characterization%20of%20Cefoxitin-Resistant%20Escherichia%20coli%20from%20Canadian%20Hospitals&rft.jtitle=Antimicrobial%20Agents%20and%20Chemotherapy&rft.au=Michael%20R.%20Mulvey&rft.aucorp=Members%20of%20the%20Canadian%20Hospital%20Epidemiology%20Committee%20are%20listed%20in%20Acknowledgments&rft.date=2005-01-01&rft.volume=49&rft.issue=1&rft.spage=358&rft.epage=365&rft.pages=358-365&rft.issn=0066-4804&rft.eissn=1098-6596&rft.coden=AACHAX&rft_id=info:doi/10.1128/AAC.49.1.358-365.2005&rft_dat=%3Cproquest_pubme%3E67336237%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17763353&rft_id=info:pmid/15616316&rfr_iscdi=true